Wells Fargo & Company »

Kintara Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Kintara Therapeutics (KTRA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Kintara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kintara Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kintara Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $314 1.6k 0.20
2024-03-31 $3 26 0.12
2023-12-31 $1 13 0.15
2023-09-30 $48 12 4.00
2023-06-30 $48 12 4.00
2022-12-31 $76 11 6.91